Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126927971 | 12692797 | 1 | I | 20151007 | 20160829 | 20160829 | EXP | JP-CIPLA LTD.-2016JP17179 | CIPLA | DOI T, YOSHINO T, FUSE N, BOKU N, YAMAZAKI K, KOIZUMI W ET AL.. PHASE I STUDY OF TAS-102 AND IRINOTECAN COMBINATION THERAPY IN JAPANESE PATIENTS WITH ADVANCED COLORECTAL CANCER. INVEST NEW DRUGS. 2015;33:1068 TO 1077 | 0.00 | Y | 0.00000 | 20160829 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126927971 | 12692797 | 1 | PS | Irinotecan | IRINOTECAN | 1 | Intravenous (not otherwise specified) | 150 MG/M2, OVER AT LEAST 90 MIN ON DAYS 1 AND 15 IN A 28-DAY CYCLE | Y | U | 77219 | 150 | MG/M**2 | INFUSION | |||||
| 126927971 | 12692797 | 2 | SS | Irinotecan | IRINOTECAN | 1 | Intravenous (not otherwise specified) | UNK, CYCLE 2 | Y | U | 77219 | INFUSION | |||||||
| 126927971 | 12692797 | 3 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126927971 | 12692797 | 4 | SS | TAS-102 | TIPIRACIL HYDROCHLORIDETRIFLURIDINE | 1 | Unknown | 60 MG/M2/DAY, BID | U | U | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126927971 | 12692797 | 1 | Colorectal cancer recurrent |
| 126927971 | 12692797 | 3 | Colorectal cancer recurrent |
| 126927971 | 12692797 | 4 | Colorectal cancer recurrent |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126927971 | 12692797 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126927971 | 12692797 | Disease progression | |
| 126927971 | 12692797 | Febrile neutropenia | |
| 126927971 | 12692797 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |